• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: OBTECH MEDICAL SARL_ SAGB QUICKCLOSE WITH VELOCITY* INJECTION PORT; IMPLANT, INTRAGASTRIC FOR MORBID OBESITY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

OBTECH MEDICAL SARL_ SAGB QUICKCLOSE WITH VELOCITY* INJECTION PORT; IMPLANT, INTRAGASTRIC FOR MORBID OBESITY Back to Search Results
Catalog Number BD3XV
Device Problem Device Dislodged or Dislocated (2923)
Patient Problem Surgical procedure, additional (2564)
Event Date 06/16/2015
Event Type  malfunction  
Event Description
It was reported that after an unknown procedure, when the patient came for a band adjustment, the port was dislocated.The surgery was done to fix it back, but the legs of the port were half open and didn¿t fix.The port was replaced by a new one.The patient got the band in (b)(6) of 2009.There were no adverse consequences for the patient reported.
 
Manufacturer Narrative
(b)(4): information anticipated, but unavailable at this time.When additional information is received and/or the device analysis has been completed, a supplemental medwatch will be sent.
 
Manufacturer Narrative
(b)(4).Additional information: hook tip ben, biological debris presence.Batch # zkbbnk the port, locking connector and tubing strain relief were returned (in three pieces).The underside of the port was returned with several scratch marks.The lot number remained visible - zkbbnk.The port was returned in unlocked position.The 3 of the 4 hooks were slightly deployed when the port was in unlocked position.The 3 of the 4 hook tips appeared to be bent.The port was tested for hook deployment.A sample port applier was used to deploy the port hooks.During the first attempt, the hooks did not deploy as intended; the hooks partially deployed.Upon the second attempt, some resistance was felt however the hooks deployed.It was observed that the hook ends were slightly bent.The velocity port was then disassembled to determine the position of the staples and the status of the hooks.Upon initial separation of the actuator ring from the port body, the location of the staples appeared correct and consistent for all four staples.Biological debris was evident inside the port.Some of the biological debris was removed and the port reassembled.After reassembly of the port, the hook deployment test was undertaken again with a positive result - the hooks could be deployed.The septum of the port was examined under microscope.5 punctures were visible in the septum.Needle punctures were also visible on the underside of the port.It is difficult to determine how many needle punctures are present on the underside (where the lot number is engraved) due to the amount of scratches visible.The port has been implanted since 2009.It would normally be expected to see more punctures on the septum under microscopic view for a port which has been implanted for 6 years.The scratches on the underside of the port are consistent with scratches as a result of needle use, in a possible attempt to fill the band.Contributing factors to port displacement include patient physical activity, port location and improper port anchoring.While it is not possible to draw definitive conclusions regarding root cause of the reported events, it is noted that port migration / port flip are recognized events associated with gastric banding and the realize adjustable gastric band.Its causes and consequences are outlined within the products' instructions for use (ifu).A device history record (dhr) review was performed, and no discrepancies were recorded during the manufacturing process.Review of manufacturing process was performed and it was noted that injection ports are 100% functionally tested prior release; therefore it is unlikely that a manufacturing issue contributed at this event description.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Type of Device
IMPLANT, INTRAGASTRIC FOR MORBID OBESITY
Manufacturer (Section D)
OBTECH MEDICAL SARL_
chemin-blanc 38
le locle CH-24 00
SZ  CH-2400
Manufacturer (Section G)
OBTECH MEDICAL SARL
chemin-blanc 38
le locle CH-2 400
SZ   CH-2400
Manufacturer Contact
guillermo villa
route 22 west po box 151
somerville, NJ 08876
9082180707
MDR Report Key4891626
MDR Text Key6831042
Report Number3005992282-2015-00032
Device Sequence Number1
Product Code LTI
Combination Product (y/n)N
Reporter Country CodeLG
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,User Facility,Company Representative
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 06/17/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/06/2015
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/31/2014
Device Catalogue NumberBD3XV
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/23/2015
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? No
Date Manufacturer Received07/30/2015
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured02/13/2009
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
-
-